IPSC - Century Therapeutics GAAP EPS of -$0.54 misses by $0.04 revenue of $1.39M beats by $0.05M
- Century Therapeutics press release ( NASDAQ: IPSC ): Q2 GAAP EPS of -$0.54 misses by $0.04 .
- Revenue of $1.39M beats by $0.05M .
- Cash, cash equivalents, and investments were $429.4 million as of June 30, 2022, as compared to $358.8 million as of December 31, 2021.
For further details see:
Century Therapeutics GAAP EPS of -$0.54 misses by $0.04, revenue of $1.39M beats by $0.05M